Corcept Therapeutics Inc (CORT) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

With 1.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.85 million shares. The 52-week range on CORT shows that it touched its highest point at $75.00 and its lowest point at $20.84 during that stretch. It currently has a 1-year price target of $97.00. Beta for the stock currently stands at 0.59.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CORT was down-trending over the past week, with a drop of -13.68%, but this was up by 7.64% over a month. Three-month performance surged to 20.75% while six-month performance rose 85.19%. The stock gained 181.40% in the past year, while it has gained 26.10% so far this year. A look at the trailing 12-month EPS for CORT yields 1.26 with Next year EPS estimates of 2.11. For the next quarter, that number is 0.43. This implies an EPS growth rate of 49.74% for this year and 49.73% for next year. EPS is expected to grow by 68.27% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 9.67%.

Float and Shares Shorts:

At present, 104.70 million CORT shares are outstanding with a float of 92.45 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CORT since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.49029 being high and $1.30401 being low. For CORT, this leads to a yearly average estimate of $1.4075. Based on analyst estimates, the high estimate for the next quarter is $0.58 and the low estimate is $0.25. The average estimate for the next quarter is thus $0.46.